eNeura Therapeutics

About:

ENeura Therapeutics is a medical technology company developing transcranial magnetic stimulation devices for the treatment of migraines.

Website: http://www.eneura.com/

Top Investors: New Enterprise Associates, InterWest Partners, Domain Associates, Johnson & Johnson Development Corporation, Camden Partners

Description:

ENeura Therapeutics is a medical technology company developing transcranial magnetic stimulation devices for the treatment of migraines. It pioneers the use of portable, non-invasive Transcranial Magnetic Stimulation (TMS) devices for the treatment of migraine. Prescribed by physicians but designed for patient use, it is the first truly portable, convenient TMS product that will allow migraine patients to administer treatment as needed—at home, in the office, or on the go.

Total Funding Amount:

$75.8M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Sunnyvale, California, United States

Founded Date:

2000-01-01

Contact Email:

CustomerCare(AT)eNeura.com

Founders:

David Fischell, Robert Fischell

Number of Employees:

11-50

Last Funding Date:

2019-11-04

IPO Status:

Private

Industries:

© 2025 bioDAO.ai